Acute Myeloid Leukemia (AML) Detection Using AlexNet Model

被引:20
|
作者
Shaheen, Maneela [1 ]
Khan, Rafiullah [1 ]
Biswal, R. R. [2 ]
Ullah, Mohib [1 ]
Khan, Atif [3 ]
Uddin, M. Irfan [4 ]
Zareei, Mahdi [2 ]
Waheed, Abdul [5 ,6 ]
机构
[1] Univ Agr, Inst Comp Sci & Informat Technol, Peshawar, Pakistan
[2] Tecnol Monterrey, Sch Sci & Engn, Zapopan, Mexico
[3] Islamia Coll Peshawar, Dept Comp Sci, Peshawar, KP, Pakistan
[4] Kohat Univ Sci & Technol, Inst Comp, Kohat, Pakistan
[5] Hazara Univ Mansehra, Dept Informat Technol, Mansehra 21120, Pakistan
[6] Seoul Natl Univ, Sch Elect & Comp Engn, Seoul 08826, South Korea
关键词
NEURAL-NETWORK; CLASSIFICATION;
D O I
10.1155/2021/6658192
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Acute Myeloid Leukemia (AML) is a kind of fatal blood cancer with a high death rate caused by abnormal cells' rapid growth in the human body. The usual method to detect AML is the manual microscopic examination of the blood sample, which is tedious and time-consuming and requires a skilled medical operator for accurate detection. In this work, we proposed an AlexNet-based classification model to detect Acute Myeloid Leukemia (AML) in microscopic blood images and compared its performance with LeNet-5-based model in Precision, Recall, Accuracy, and Quadratic Loss. The experiments are conducted on a dataset of four thousand blood smear samples. The results show that AlexNet was able to identify 88.9% of images correctly with 87.4% precision and 98.58% accuracy, whereas LeNet-5 correctly identified 85.3% of images with 83.6% precision and 96.25% accuracy.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] AngioCRIME in Acute Myeloid Leukemia (AML)
    Macintyre, Elizabeth
    HEMASPHERE, 2017, 1 (01):
  • [2] Rapid Detection of Blood Stream Pathogens in Acute Myeloid Leukemia (AML)
    Hosni, Amal Mohammed
    Tolba, Marwa Mohammed Mohammed
    Elateef, Hanan Harith Abd
    Krisha, Mohamed Zakaria Abo
    Aly, Mai Mostafa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S281 - S281
  • [3] The Detection of Clonal Evolution in Acute Myeloid Leukemia (AML) Using SNP/CGH Microarray Analysis
    Hartmann, L.
    Stephenson, C. F.
    Johnson, K. R.
    Chapman, D. B.
    Bennington, R. K.
    Fritschle, W. K.
    Eidenschink, L.
    Wells, D. A.
    Loken, M. R.
    de Baca, M. E.
    Zehentner, B. K.
    MODERN PATHOLOGY, 2013, 26 : 494A - 494A
  • [4] The Detection of Clonal Evolution in Acute Myeloid Leukemia (AML) Using SNP/CGH Microarray Analysis
    Hartmann, L.
    Stephenson, C. F.
    Johnson, K. R.
    Chapman, D. B.
    Bennington, R. K.
    Fritschle, W. K.
    Eidenschink, L.
    Wells, D. A.
    Loken, M. R.
    de Baca, M. E.
    Zehentner, B. K.
    LABORATORY INVESTIGATION, 2013, 93 : 494A - 494A
  • [5] A Murine Immunocompetent Acute Myeloid Leukemia (AML) Model for Testing Immunotherapies
    Lee, Hui Mei
    Zandvakilli, Niloofar
    Desai, Rhea
    Kakadia, Purvi M.
    Browett, Peter
    Bohlander, Stefan K.
    BLOOD, 2020, 136
  • [6] Mylotarg in the therapy of acute myeloid leukemia (AML).
    Weber-Nordt, RM
    Lenze, A
    Gottschling, S
    Steiger, S
    Ho, AD
    BLOOD, 2001, 98 (11) : 225B - 225B
  • [7] ACUTE MYELOID LEUKEMIA (AML)-PROGRESS AND PROMISES
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2016, 49 : S2 - S3
  • [8] New agents in acute myeloid leukemia (AML)
    Park, Silvia
    Cho, Byung Sik
    Kim, Hee-Je
    BLOOD RESEARCH, 2020, 55 : 14 - 18
  • [9] Chromosomal rearrangements in acute myeloid leukemia (AML)
    Belloni, E.
    Trubia, M.
    Gasparini, P.
    Micucci, C.
    Tapinassi, C.
    Confalonieri, S.
    Nuciforo, P.
    Martino, B.
    Lo-Coco, F.
    Di Fiore, P. P.
    Pelicci, P. G.
    ECANCERMEDICALSCIENCE, 2010, 4
  • [10] THERAPEUTIC TARGETS FOR ACUTE MYELOID LEUKEMIA (AML)
    Sorbera, L. A.
    Verges, C.
    Dulsat, C.
    DRUGS OF THE FUTURE, 2009, 34 (01) : 67 - 77